Drug Transporter (DT) Information

General Information of DT
DT ID DTD0502
Gene Name SLCO4A1
Protein Name Organic anion transporting polypeptide 4A1
Gene ID
28231
UniProt ID
Q96BD0
TCDB ID
2.A.60.1.9
3D Structure

Modelled DT Structure

Method: multi-sequence alignment based machine learning

Detail: Structure Info

Synonyms Colon organic anion transporter; OATP-E; OATP-RP1; OATP4A1; OATPE; OATPRP1; Organic anion transporter polypeptide-related protein 1; Organic anion-transporting polypeptide E; POAT; SLC21A12; SLCO4A1; Sodium-independent organic anion transporter E; Solute carrier family 21 member 12; Solute carrier organic anion transporter family member 4A1
DT Family Organo Anion Transporter (OAT) Family ;
Tissue Specificity Ubiquitous, with the exception of spleen andleukocytes.
Function This Na(+)-independent transporter mediates the transport of organic anions such as the thyroid hormones T3 (triiodo-L-thyronine), T4 (thyroxine) and rT3, and of estrone-3-sulfate and taurocholate.
Disease(s) Medical abortion [ICD-11: JA00.1]
Endogenous Substrate(s) Eicosanoids; Thyroid hormones; Bile salts
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(β) Post-translational Modification of This DT
Post-translational Modification (PTM)

(γ) Transcriptional Regulation of This DT
Transcriptional Regulation (TSR)

(δ) Epigenetic Regulation of This DT
Epigenetic Regulation (EGR)

(ε) Exogenous Modulation of This DT
Exogenous Modulation (EGM)

Structural Variability Data of This DT (VARIDT 2.0)

(β) Inter-species Structural Differences
Inter-species Structural Differences (ISD)

General Variability Data of This DT (VARIDT 1.0)

(β) Disease-specific Protein Abundances of This DT
Disease-specific Protein Abundances of This DT (DPAD)

(γ) Species- and Tissue-specific DT Abundances
Species/Tissue-specific Protein Abundances of This DT (S/TPAD)
Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Approved Drug

 Click to Show/Hide the Full List of Drug:            3 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Dinoprostone
 Approved Drug Info Medical abortion JA00.1 [1]
Estrone sulfate
 Approved Drug Info Menopausal symptoms MF32 [2]
Liothyronine
 Approved Drug Info Hypothyroidism 5A00.2 [3]

 Clinical Trial Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Benzylpenicillin
 Phase 4 Drug Info Gram-positive bacteria infections 1A00-1H0Z [1]

 Withdrawn, Discontinued or Preclinical Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Taurocholic acid
 Terminated Drug Info Type 2 diabetes 5A11 [4]

Drug-DT Affinity Assessed by Cell Line

 Approved Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Cell Line Affinity Ref
Liothyronine Approved Drug Info Oocytes-OATP4A1 Km = 0.9 microM [4]

 Withdrawn, Discontinued or Preclinical Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Cell Line Affinity Ref
Taurocholic acid Terminated Drug Info Oocytes-OATP4A1 Km = 14.9 microM [4]
References
1 Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun. 2000 Jun 24;273(1):251-60.
2 Involvement of estrone-3-sulfate transporters in proliferation of hormone-dependent breast cancer cells. J Pharmacol Exp Ther. 2004 Dec;311(3):1032-7.
3 Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney. Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3569-74.
4 Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner. Endocrinology. 2001 May;142(5):2005-12.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.